Takahashi K, Yamanaka S (agosto de 2006). "Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors". Cell126 (4): 663–76. PMID16904174. doi:10.1016/j.cell.2006.07.024.
Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, Yamanaka S (novembro de 2007). "Induction of pluripotent stem cells from adult human fibroblasts by defined factors". Cell131 (5): 861–72. PMID18035408. doi:10.1016/j.cell.2007.11.019.
Maherali N, Sridharan R, Xie W, Utikal J, Eminli S, Arnold K, Stadtfeld M, Yachechko R, Tchieu J, Jaenisch R, Plath K, Hochedlinger K (xuño de 2007). "Directly reprogrammed fibroblasts show global epigenetic remodeling and widespread tissue contribution". Cell Stem Cell1 (1): 55–70. PMID18371336. doi:10.1016/j.stem.2007.05.014.
Klimanskaya I, Chung Y, Becker S, Lu SJ, Lanza R (novembro de 2006). "Human embryonic stem cell lines derived from single blastomeres". Nature444 (7118): 481–5. PMID16929302. doi:10.1038/nature05142.
Okita K, Ichisaka T, Yamanaka S (xullo de 2007). "Generation of germline-competent induced pluripotent stem cells". Nature448 (7151): 313–7. PMID17554338. doi:10.1038/nature05934.
Wernig M, Meissner A, Foreman R, Brambrink T, Ku M, Hochedlinger K, Bernstein BE, Jaenisch R (xullo de 2007). "In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state". Nature448 (7151): 318–24. PMID17554336. doi:10.1038/nature05944.
Yu J, Vodyanik MA, Smuga-Otto K, Antosiewicz-Bourget J, Frane JL, Tian S, Nie J, Jonsdottir GA, Ruotti V, Stewart R, Slukvin II, Thomson JA (decembro de 2007). "Induced pluripotent stem cell lines derived from human somatic cells". Science318 (5858): 1917–20. PMID18029452. doi:10.1126/science.1151526.
Okita K, Nakagawa M, Hyenjong H, Ichisaka T, Yamanaka S (novembro de 2008). "Generation of mouse induced pluripotent stem cells without viral vectors". Science322 (5903): 949–53. PMID18845712. doi:10.1126/science.1164270.
Yamanaka S (xullo de 2010). "Patient-specific pluripotent stem cells become even more accessible". Cell Stem Cell7 (1): 1–2. PMID20621038. doi:10.1016/j.stem.2010.06.009.
Maherali N, Hochedlinger K (decembro de 2008). "Guidelines and techniques for the generation of induced pluripotent stem cells". Cell Stem Cell3 (6): 595–605. PMID19041776. doi:10.1016/j.stem.2008.11.008.
Zhao XY, Li W, Lv Z, Liu L, Tong M, Hai T, Hao J, Guo CL, Ma QW, Wang L, Zeng F, Zhou Q (septembro de 2009). "iPS cells produce viable mice through tetraploid complementation". Nature461 (7260): 86–90. PMID19672241. doi:10.1038/nature08267.
Kang L, Wang J, Zhang Y, Kou Z, Gao S (agosto de 2009). "iPS cells can support full-term development of tetraploid blastocyst-complemented embryos". Cell Stem Cell5 (2): 135–8. PMID19631602. doi:10.1016/j.stem.2009.07.001.
Boland MJ, Hazen JL, Nazor KL, Rodriguez AR, Gifford W, Martin G, Kupriyanov S, Baldwin KK (septembro de 2009). "Adult mice generated from induced pluripotent stem cells". Nature461 (7260): 91–4. PMID19672243. doi:10.1038/nature08310.
Luo M, Ling T, Xie W, Sun H, Zhou Y, Zhu Q, Shen M, Zong L, Lyu G, Zhao Y, Ye T, Gu J, Tao W, Lu Z, Grummt I (xullo de 2013). "NuRD blocks reprogramming of mouse somatic cells into pluripotent stem cells". Stem Cells31 (7): 1278–86. PMID23533168. doi:10.1002/stem.1374.
Takahashi K, Yamanaka S (agosto de 2006). "Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors". Cell126 (4): 663–76. PMID16904174. doi:10.1016/j.cell.2006.07.024.
Liu J, Verma PJ, Evans-Galea MV, Delatycki MB, Michalska A, Leung J, Crombie D, Sarsero JP, Williamson R, Dottori M et al (2011). "Generation of induced pluripotent stem cell lines from Friedreich ataxia patients". Stem Cell Rev 7 (3): 703-713. (http://www.ncbi.nlm.nih.gov/pubmed/21181307).
Liu SP, Fu RH, Huang YC, Chen SY, Chien YJ, Hsu CY, Tsai CH, Shyu WC, Lin SZ (2011). "Induced pluripotent stem (iPS) cell research overview". Cell Transplant 20 (1): 15-19. (http://www.ncbi.nlm.nih.gov/pubmed/20887681).
Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, Yamanaka S (novembro de 2007). "Induction of pluripotent stem cells from adult human fibroblasts by defined factors". Cell131 (5): 861–72. PMID18035408. doi:10.1016/j.cell.2007.11.019.
Miller JD, Schlaeger TM (2011). "Generation of induced pluripotent stem cell lines from human fibroblasts via retroviral gene transfer". Methods Mol Biol 767 55-65. (http://www.ncbi.nlm.nih.gov/pubmed/21822867).
Maherali N, Sridharan R, Xie W, Utikal J, Eminli S, Arnold K, Stadtfeld M, Yachechko R, Tchieu J, Jaenisch R, Plath K, Hochedlinger K (xuño de 2007). "Directly reprogrammed fibroblasts show global epigenetic remodeling and widespread tissue contribution". Cell Stem Cell1 (1): 55–70. PMID18371336. doi:10.1016/j.stem.2007.05.014.
Klimanskaya I, Chung Y, Becker S, Lu SJ, Lanza R (novembro de 2006). "Human embryonic stem cell lines derived from single blastomeres". Nature444 (7118): 481–5. PMID16929302. doi:10.1038/nature05142.
Okita K, Ichisaka T, Yamanaka S (xullo de 2007). "Generation of germline-competent induced pluripotent stem cells". Nature448 (7151): 313–7. PMID17554338. doi:10.1038/nature05934.
Wernig M, Meissner A, Foreman R, Brambrink T, Ku M, Hochedlinger K, Bernstein BE, Jaenisch R (xullo de 2007). "In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state". Nature448 (7151): 318–24. PMID17554336. doi:10.1038/nature05944.
Nakagawa M, Koyanagi M, Tanabe K, Takahashi K, Ichisaka T, Aoi T, Okita K, Mochiduki Y, Takizawa N, Yamanaka S (2008). "Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts". Nat Biotechnol 26 (1): 101-106. (http://www.ncbi.nlm.nih.gov/pubmed/18059259).
Yu J, Vodyanik MA, Smuga-Otto K, Antosiewicz-Bourget J, Frane JL, Tian S, Nie J, Jonsdottir GA, Ruotti V, Stewart R, Slukvin II, Thomson JA (decembro de 2007). "Induced pluripotent stem cell lines derived from human somatic cells". Science318 (5858): 1917–20. PMID18029452. doi:10.1126/science.1151526.
Dick E, Matsa E, Bispham J, Reza M, Guglieri M, Staniforth A, Watson S, Kumari R, Lochmuller H, Young L et al (2011). "Two new protocols to enhance the production and isolation of human induced pluripotent stem cell lines". Stem Cell Res 6 (2): 158-167. (http://www.ncbi.nlm.nih.gov/pubmed/21095172).
Chung HC, Lin RC, Logan GJ, Alexander IE, Sachdev PS, Sidhu KS (2011). "Human Induced Pluripotent Stem Cells Derived Under Feeder-Free Conditions Display Unique Cell Cycle and DNA Replication Gene Profiles". Stem Cells Dev (http://www.ncbi.nlm.nih.gov/pubmed/21506733).
Nemati S, Hatami M, Kiani S, Hemmesi K, Gourabi H, Masoudi N, Alaei S, Baharvand H (2011). "Long-term self-renewable feeder-free human induced pluripotent stem cell-derived neural progenitors". Stem Cells Dev 20 (3): 503-514. (http://www.ncbi.nlm.nih.gov/pubmed/20632795).
Selvaraj V, Plane JM, Williams AJ, Deng W (2010). "Switching cell fate: the remarkable rise of induced pluripotent stem cells and lineage reprogramming technologies". Trends Biotechnol 28 (4): 214-223. (http://www.ncbi.nlm.nih.gov/pubmed/20149468).
Okita K, Nakagawa M, Hyenjong H, Ichisaka T, Yamanaka S (novembro de 2008). "Generation of mouse induced pluripotent stem cells without viral vectors". Science322 (5903): 949–53. PMID18845712. doi:10.1126/science.1164270.
Stadtfeld M, Nagaya M, Utikal J, Weir G, Hochedlinger K (2008). "Induced pluripotent stem cells generated without viral integration". Science 322 (5903): 945-949. (http://www.ncbi.nlm.nih.gov/pubmed/18818365).
Woltjen K, Michael IP, Mohseni P, Desai R, Mileikovsky M, Hamalainen R, Cowling R, Wang W, Liu P, Gertsenstein M et al (2009). "piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells". Nature 458 (7239): 766-770. (http://www.ncbi.nlm.nih.gov/pubmed/19252478).
Yamanaka S (xullo de 2010). "Patient-specific pluripotent stem cells become even more accessible". Cell Stem Cell7 (1): 1–2. PMID20621038. doi:10.1016/j.stem.2010.06.009.
Marion RM, Strati K, Li H, Murga M, Blanco R, Ortega S, Fernandez-Capetillo O, Serrano M, Blasco MA (2009). "A p53-mediated DNA damage response limits reprogramming to ensure iPS cell genomic integrity". Nature 460 (7259): 1149-1153. (http://www.ncbi.nlm.nih.gov/pubmed/19668189).
Maherali N, Hochedlinger K (decembro de 2008). "Guidelines and techniques for the generation of induced pluripotent stem cells". Cell Stem Cell3 (6): 595–605. PMID19041776. doi:10.1016/j.stem.2008.11.008.
Kim K, Zhao R, Doi A, Ng K, Unternaehrer J, Cahan P, Hongguang H, Loh YH, Aryee MJ, Lensch MW et al (2011). "Donor cell type can influence the epigenome and differentiation potential of human induced pluripotent stem cells". Nat Biotechnol 29 (12): 1117-1119. (http://www.ncbi.nlm.nih.gov/pubmed/22119740).
Zhao XY, Li W, Lv Z, Liu L, Tong M, Hai T, Hao J, Guo CL, Ma QW, Wang L, Zeng F, Zhou Q (septembro de 2009). "iPS cells produce viable mice through tetraploid complementation". Nature461 (7260): 86–90. PMID19672241. doi:10.1038/nature08267.
Li Z, Hu S, Ghosh Z, Han Z, Wu JC (2011). "Functional characterization and expression profiling of human induced pluripotent stem cell- and embryonic stem cell-derived endothelial cells". Stem Cells Dev 20 (10): 1701-1710. (http://www.ncbi.nlm.nih.gov/pubmed/21235328).
Narsinh KH, Sun N, Sanchez-Freire V, Lee AS, Almeida P, Hu S, Jan T, Wilson KD, Leong D, Rosenberg J et al (2011). "Single cell transcriptional profiling reveals heterogeneity of human induced pluripotent stem cells". J Clin Invest 121 (3): 1217-1221. (http://www.ncbi.nlm.nih.gov/pubmed/21317531).
Huangfu D, Maehr R, Guo W, Eijkelenboom A, Snitow M, Chen AE, Melton DA (2008). "Induction of pluripotent stem cells by defined factors is greatly improved by small-molecule compounds". Nat Biotechnol 26 (7): 795-797. (http://www.ncbi.nlm.nih.gov/pubmed/18568017).
Shi Y, Desponts C, Do JT, Hahm HS, Scholer HR, Ding S (2008). "Induction of pluripotent stem cells from mouse embryonic fibroblasts by Oct4 and Klf4 with small-molecule compounds". Cell Stem Cell 3 (5): 568-574. (http://www.ncbi.nlm.nih.gov/pubmed/18983970).
Lin SL (2011). "Concise review: Deciphering the mechanism behind induced pluripotent stem cell generation". Stem Cells 29 (11): 1645-1649. (http://www.ncbi.nlm.nih.gov/pubmed/21948625).
Lin Z, Perez P, Lei D, Xu J, Gao X, Bao J (2011). "Two-phase analysis of molecular pathways underlying induced pluripotent stem cell induction". Stem Cells 29 (12): 1963-1974. (http://www.ncbi.nlm.nih.gov/pubmed/21956995).
Zhou H, Wu S, Joo JY, Zhu S, Han DW, Lin T, Trauger S, Bien G, Yao S, Zhu Y et al (2009). "Generation of induced pluripotent stem cells using recombinant proteins". Cell Stem Cell 4 (5): 381-384. (http://www.ncbi.nlm.nih.gov/pubmed/19398399).
Kang L, Wang J, Zhang Y, Kou Z, Gao S (agosto de 2009). "iPS cells can support full-term development of tetraploid blastocyst-complemented embryos". Cell Stem Cell5 (2): 135–8. PMID19631602. doi:10.1016/j.stem.2009.07.001.
Boland MJ, Hazen JL, Nazor KL, Rodriguez AR, Gifford W, Martin G, Kupriyanov S, Baldwin KK (septembro de 2009). "Adult mice generated from induced pluripotent stem cells". Nature461 (7260): 91–4. PMID19672243. doi:10.1038/nature08310.
Taylor CJ, Bolton EM, Bradley JA (2011). "Immunological considerations for embryonic and induced pluripotent stem cell banking". Philos Trans R Soc Lond B Biol Sci 366 (1575): 2312-2322. (http://www.ncbi.nlm.nih.gov/pubmed/21727137).
Ananiev G, Williams EC, Li H, Chang Q (2011). "Isogenic pairs of wild type and mutant induced pluripotent stem cell (iPSC) lines from Rett syndrome patients as in vitro disease model". Plos One 6 (9): e25255. (http://www.ncbi.nlm.nih.gov/pubmed/21966470).
Priori SG (2011). "Induced pluripotent stem cell-derived cardiomyocytes and long QT syndrome: is personalized medicine ready for prime time?". Circ Res 109 (8): 822-824. (http://www.ncbi.nlm.nih.gov/pubmed/21960720).
Sheridan SD, Theriault KM, Reis SA, Zhou F, Madison JM, Daheron L, Loring JF, Haggarty SJ (2011). "Epigenetic characterization of the FMR1 gene and aberrant neurodevelopment in human induced pluripotent stem cell models of fragile X syndrome". Plos One 6 (10): e26203. (http://www.ncbi.nlm.nih.gov/pubmed/22022567).
Chang T, Zheng W, Tsark W, Bates S, Huang H, Lin RJ, Yee JK (2011). "Brief report: phenotypic rescue of induced pluripotent stem cell-derived motoneurons of a spinal muscular atrophy patient". Stem Cells 29 (12): 2090-2093. http://www.ncbi.nlm.nih.gov/pubmed/21956898).
Josowitz R, Carvajal-Vergara X, Lemischka IR, Gelb BD (2011). "Induced pluripotent stem cell-derived cardiomyocytes as models for genetic cardiovascular disorders". Curr Opin Cardiol 26 (3): 223-229. (http://www.ncbi.nlm.nih.gov/pubmed/21451408).
Luo M, Ling T, Xie W, Sun H, Zhou Y, Zhu Q, Shen M, Zong L, Lyu G, Zhao Y, Ye T, Gu J, Tao W, Lu Z, Grummt I (xullo de 2013). "NuRD blocks reprogramming of mouse somatic cells into pluripotent stem cells". Stem Cells31 (7): 1278–86. PMID23533168. doi:10.1002/stem.1374.